Jupiter Life Line Hospitals (JLHL) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
26 Oct, 2026Executive summary
Q2FY27 total income was INR 456.5 crore (+16.0% YoY), EBITDA INR 106.9 crore (+15.9%) and PAT INR 56.359 crore (-1.7%).
H1FY27 total income was INR 867.479 crore (+16.2% YoY), EBITDA INR 186.2 crore (+9.1%) and PAT INR 93.871 crore (-7.4%).
Existing hospitals performed in line with expectations; Dombivli's Q2 EBITDA loss narrowed to INR 0.2 crore from INR 9.5 crore in Q1, while its H1 loss was INR 9.7 crore.
Bed capacity is planned to expand from 1,700 to 2,900; Pune South construction is on schedule and its land acquisition was approved.
Financial highlights
Q2FY27 revenue from operations was INR 436.3 crore (+15.8% YoY); total income was INR 456.5 crore (+16.0%), EBITDA INR 106.9 crore, PBT INR 75.1 crore and PAT INR 56.4 crore.
H1FY27 revenue from operations was INR 828.8 crore (+16.0% YoY); total income was INR 867.5 crore (+16.2%), PBT INR 125.7 crore (-7.6%) and PAT INR 93.9 crore (-7.4%).
H1 operating cash flow was INR 136.1 crore versus INR 130.2 crore; investing outflow was INR 176.3 crore and financing inflow INR 28.4 crore.
Standalone Q2 revenue was INR 364.597 crore and net profit INR 51.454 crore; H1 revenue was INR 693.082 crore and net profit INR 88.643 crore.
Outlook and guidance
Planned projects target 2,900 beds: Pune II (500 beds, CY28), Mira-Bhayandar (300 beds, CY29) and BKC (400 beds, CY31).
Dombivli is commissioning in phases, with ~200 beds operational and fit-outs completed for another 100; transplants are expected to start in the next couple of quarters and radiation oncology in the next quarter.
Management expects new hospitals to face budgeted EBITDA drag for roughly two years and will reassess Dombivli expectations after 1–2 quarters; its case mix and ARPOB are expected to mature over 2–3 years.
Indore bed additions are not expected for the next couple of quarters; occupancy needs to reach the mid-60s from the current mid-to-high-50s before expansion.
Dombivli occupancy was in the mid-30s; insurance empanelment is ongoing and typically takes about a year, with improved local access expected after completion.
Latest events from Jupiter Life Line Hospitals
- FY2023 profit rose as hospital revenues grew and IPO preparations advanced.JLHL
Q4 22/23 - FY22 revenue and profit advanced as COVID costs coincided with hospital expansion plans.JLHL
Q4 21/22 - Flat FY21 revenue masked lower profit amid COVID-19 disruption.JLHL
Q4 20/21 - H1 income grew 19.8%, debt was repaid, and Indore reached EBITDA break-even.JLHL
Q2 23/24 - Occupancy climbed and debt was cleared, while PAT benefited from a deferred-tax credit.JLHL
Q1 23/24 - Q1 FY27 revenue grew 16.2% to ₹4,109.83 million, with margin pressure from expansion.JLHL
Q1 26/27 - Q1 FY25 saw strong revenue and EBITDA growth, digital accreditation, and capacity expansion.JLHL
Q1 24/25 - Q3 FY26 income and EBITDA rose, but PAT fell due to labor code; major hospital expansion underway.JLHL
Q3 25/26 - Strong revenue and profit growth, major hospital expansion, and robust internal funding.JLHL
Q3 24/25